John Dongas
Clinical Cardiac Electrophysiology · New Lenox, ILNPI 1003864331
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 294 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,130 and has fallen 98.8% since, to $26 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IL, where the typical reported total is $24,482.
Across 294 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Preventric Diagnostics, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$527
- Boston Scientific$500
- Novartis$492
- Boehringer Ingelheim$480
- Johnson & Johnson$369
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,564100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Preventric Diagnostics, Inc. | 3 | $1,273 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $527 |
| Boston Scientific | 18 | $500 |
| Novartis | 35 | $492 |
| Boehringer Ingelheim | 22 | $480 |
| Johnson & Johnson | 27 | $369 |
| Pfizer | 23 | $336 |
| Sanofi-aventis U.S. LLC | 16 | $260 |
| AstraZeneca | 17 | $251 |
| Regeneron Healthcare Solutions, Inc. | 11 | $238 |
| Esperion Therapeutics, Inc. | 5 | $237 |
| Novo Nordisk | 9 | $187 |
| Lundbeck LLC | 8 | $152 |
| Elutia, Inc. | 7 | $150 |
| Amgen | 9 | $144 |
| Merck | 9 | $134 |
| Abbott | 2 | $123 |
| E.r. Squibb & Sons, L.L.C. | 8 | $102 |
| Amarin Pharma, Inc. | 5 | $86 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $71 |
| Biotronik Inc. | 4 | $65 |
| Chiesi USA, Inc. | 4 | $64 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Bayer | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Medtronic(2 entities) | 2 | $27 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Lantheus Medical Imaging, Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $20 |
| Akcea Therapeutics, Inc. | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,590 in reported general payments places this provider in the 20th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 122 | $143,648 |
| EntrestoSacubitril/Valsartan | 49 | $55,746 |
| XareltoRivaroxaban | 12 | $13,152 |
| JardianceEmpagliflozin | 13 | $9,990 |
| Flecainide Acetate | 69 | $2,495 |
| Metoprolol Succinate | 68 | $1,275 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $951 |
| Carvedilol | 43 | $460 |
| Valsartan | 16 | $390 |
| Atorvastatin Calcium | 20 | $211 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 11 | $197 |
| Digoxin | 14 | $176 |
| Potassium Chloride | 15 | $168 |
| Amlodipine Besylate | 22 | $150 |
| Hydralazine Hcl | 15 | $142 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $336 | $143,648122 claims |
| NovartisEntresto | $492 | $55,74649 claims |
| Johnson & JohnsonXarelto | $369 | $13,15212 claims |
| Boehringer IngelheimJardiance | $480 | $9,99013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in New Lenox
- Mansour RazminiaPalos Heights$927K
- Mark MetzlEvanston$799K
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Henry HuangGeneva$501K
- Kousik KrishnanNaperville$311K
- Hany DemoChicago$297K
- Cash CaseyElmhurst$287K
- Moeen SaleemNaperville$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.